JPWO2021001326A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021001326A5
JPWO2021001326A5 JP2021577316A JP2021577316A JPWO2021001326A5 JP WO2021001326 A5 JPWO2021001326 A5 JP WO2021001326A5 JP 2021577316 A JP2021577316 A JP 2021577316A JP 2021577316 A JP2021577316 A JP 2021577316A JP WO2021001326 A5 JPWO2021001326 A5 JP WO2021001326A5
Authority
JP
Japan
Prior art keywords
compound
acid
subject
therapeutic composition
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021577316A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022538286A (ja
Publication date
Priority claimed from GBGB1909506.6A external-priority patent/GB201909506D0/en
Application filed filed Critical
Publication of JP2022538286A publication Critical patent/JP2022538286A/ja
Publication of JPWO2021001326A5 publication Critical patent/JPWO2021001326A5/ja
Pending legal-status Critical Current

Links

JP2021577316A 2019-07-02 2020-06-29 シナプス変性症の処置における使用のためのメチルチオニニウム Pending JP2022538286A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1909506.6A GB201909506D0 (en) 2019-07-02 2019-07-02 Synaptopathies
GB1909506.6 2019-07-02
PCT/EP2020/068306 WO2021001326A1 (en) 2019-07-02 2020-06-29 Methylthioninium for use in the treatment of synaptopathies

Publications (2)

Publication Number Publication Date
JP2022538286A JP2022538286A (ja) 2022-09-01
JPWO2021001326A5 true JPWO2021001326A5 (pt) 2023-07-07

Family

ID=67540130

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021577316A Pending JP2022538286A (ja) 2019-07-02 2020-06-29 シナプス変性症の処置における使用のためのメチルチオニニウム

Country Status (12)

Country Link
US (1) US20220370470A1 (pt)
EP (1) EP3993805A1 (pt)
JP (1) JP2022538286A (pt)
KR (1) KR20220029711A (pt)
CN (1) CN114080224A (pt)
AU (1) AU2020300792A1 (pt)
BR (1) BR112021025383A2 (pt)
CA (1) CA3143787A1 (pt)
GB (1) GB201909506D0 (pt)
IL (1) IL289371A (pt)
MX (1) MX2021015288A (pt)
WO (1) WO2021001326A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3121169T3 (pl) 2006-07-11 2022-05-23 Wista Laboratories Ltd. Sposoby syntezy i/lub oczyszczania związków diaminofenotiazyniowych

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020040032A1 (en) 2000-07-07 2002-04-04 Glasky Michelle S. Methods for stimulation of synthesis of synaptophysin in the central nervous system
GB0100119D0 (en) 2001-01-03 2001-02-14 Univ Aberdeen Materials and methods relating to protein aggregation in neurodegenerative disease
AU2007231124B2 (en) 2006-03-29 2013-02-21 Wista Laboratories Ltd. 3,7-diamino-10H-phenothiazine salts and their use
EP2167095B1 (en) 2007-06-19 2019-05-29 WisTa Laboratories Ltd. Phenothiazine compounds for treating mild cognitive impairment
MY161656A (en) 2007-10-03 2017-04-28 Wista Lab Ltd Therapeutic use of diaminophenothiazines
MY165906A (en) 2011-02-11 2018-05-18 Wista Lab Ltd Phenothiazine diaminium salts and their use
SG11201900228YA (en) 2016-07-25 2019-02-27 Wista Lab Ltd Administration and dosage of diaminophenothiazines
GB201614834D0 (en) 2016-09-01 2016-10-19 Wista Lab Ltd Treatment of dementia
JP6756661B2 (ja) 2017-04-28 2020-09-16 日立オートモティブシステムズ株式会社 車両電子制御装置

Similar Documents

Publication Publication Date Title
JP7457401B2 (ja) 毒性アルデヒド関連疾患および処置
US11083719B2 (en) Gel containing Pirfenidone
JP2018518537A5 (pt)
JP2018035197A5 (pt)
JP2015521617A5 (pt)
JP2019507781A5 (pt)
JP2015511609A5 (pt)
JP2019535723A5 (pt)
ES2449340T3 (es) Compuestos calcimiméticos para su uso en el tratamiento de trastornos intestinales
JP2018537507A (ja) 加齢に関連する認知障害及び神経炎症を予防及び/又は治療する方法
JP2019529541A5 (pt)
JP7334266B2 (ja) 眼疾患治療用の組成物および方法
JP2015180673A (ja) トランスノルセルトラリン及びセロトニン受容体1a作動剤/拮抗剤を含む組成物及びその使用
JP2020531511A5 (pt)
US20100035927A1 (en) Medicament for prophylactic and/or therapeutic treatment of alzheimer-type dementia
JP2009526834A5 (pt)
JPWO2021001326A5 (pt)
EP2982382A1 (en) Compounds for preventing ototoxicity
JP2012513972A5 (pt)
WO2023081482A9 (en) Combination of a bile acid and a phenyl butyrate compound for the treatment of neurodegenerative diseases
JP2005247821A (ja) 炎症性サイトカインの産生を抑制するための眼科用組成物
JP2021105061A (ja) アミロイド線維形成の抑制又は阻害剤
JP2020511437A5 (pt)
JP2007519701A5 (pt)
ES2581247T3 (es) Agente terapéutico para la enfermedad corneal